Format

Send to

Choose Destination
Am J Surg. 2013 Jul;206(1):86-95. doi: 10.1016/j.amjsurg.2012.08.007. Epub 2013 Feb 11.

Update on clinical trials for the prevention of acute kidney injury in patients undergoing cardiac surgery.

Author information

1
Division of Nephrology, Hypertension, and Renal Transplantation, University of Florida, P.O. Box 100224, Gainesville, FL 32610-0224, USA.

Abstract

BACKGROUND:

Effective therapeutic agents for the prevention and treatment of acute kidney injury (AKI) after cardiac surgery remain elusive despite the tremendous advances in surgical techniques, technology, and understanding of disease processes. Recent developments and their effect on the incidence of AKI after cardiac surgery are discussed.

DATA SOURCES:

Published clinical trials in PubMed, strength of evidence assessed by the guidelines of the American Family Physicians.

CONCLUSIONS:

The definition of AKI has changed, and the focus of interventions has shifted from treatment to prevention to recovery from AKI. Antioxidants and biological agents have been added to classic armaments of hydration and diuretics in addition to tighter metabolic control to prevent AKI. Although the treatment options remain unsatisfactory, a lot of progress nevertheless continues to be made in the prevention and treatment of AKI.

PMID:
23411349
DOI:
10.1016/j.amjsurg.2012.08.007
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center